On the contrary, other studies have demonstrated that SOX2 overexpression promotes EMT and lymph node metastasis [42–47] while SOX2 knockdown inhibits HNSCC cell self-renewal and chemoresistance [34]. Here, SOX2 is linked to head and neck squamous cell carcinoma.